Search results for "Atrophy"

showing 10 items of 385 documents

Lithium prevents grey matter atrophy in patients with bipolar disorder: an international multicenter study

2020

AbstractBackgroundLithium (Li) is the gold standard treatment for bipolar disorder (BD). However, its mechanisms of action remain unknown but include neurotrophic effects. We here investigated the influence of Li on cortical and local grey matter (GM) volumes in a large international sample of patients with BD and healthy controls (HC).MethodsWe analyzed high-resolution T1-weighted structural magnetic resonance imaging scans of 271 patients with BD type I (120 undergoing Li) and 316 HC. Cortical and local GM volumes were compared using voxel-wise approaches with voxel-based morphometry and SIENAX using FSL. We used multiple linear regression models to test the influence of Li on cortical an…

AdultMalemedicine.medical_specialtyBipolar DisorderLithium (medication)[SDV]Life Sciences [q-bio]UrologyGrey matterGyrus CinguliHippocampus03 medical and health sciences0302 clinical medicineAtrophyAntimanic AgentsmedicineHumansIn patientBipolar disorderGray MatterPathologicalApplied PsychologyComputingMilieux_MISCELLANEOUSGrey matter atrophybusiness.industryConfoundinggrey matter volumeMiddle Agedmedicine.diseaseMagnetic Resonance ImagingTemporal Lobe3. Good health030227 psychiatryPsychiatry and Mental healthmedicine.anatomical_structurelithiumCase-Control StudiesLithium CompoundsFemaleAtrophybusiness030217 neurology & neurosurgeryMRImedicine.drug
researchProduct

Esophageal dysfunction and its pathogenesis in progressive systemic sclerosis

1978

In 25 patients with progressive systemic sclerosis esophageal involvement was studied prospectively by analysing subjective symptoms and radiological and manometric criteria. In all patients abnormal motility could be demonstrated by X-ray and/or manometry: radiologically in 18 (72%), manometrically in 22 (88%) cases. Dysphagia was present only in 11 patients (44%). Six patients (24%) had no subjective symptoms in spite of severe objective esophageal abnormalities. Therefore, the absence of esophageal symptoms does not exclude advanced affliction of the esophagus. To determine the pathogenesis of esophageal dysfunction the effects of 3.5 microgram/kg carbachol and of 0.6 microgram/kg pentag…

AdultMalemedicine.medical_specialtyCarbacholManometryGastroenterologySclerodermaPathogenesisEsophagusAtrophyInternal medicineDrug DiscoverymedicineHumansEsophagusGenetics (clinical)AgedPeristalsisScleroderma Systemicbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseDysphagiaSurgeryPentagastrinmedicine.anatomical_structureMolecular MedicineCarbacholFemalePentagastrinPeristalsismedicine.symptomDeglutition Disordersbusinessmedicine.drugKlinische Wochenschrift
researchProduct

Prospective study of morphologic and functional changes with time in the mucosa of the ileoanal pouch: functional appraisal using transmucosal potent…

1998

PURPOSE: This study was undertaken to investigate the morphologic and functional changes with time in the mucosa of the ileoanal pouch. METHODS: A morphologic study by histopathologic analysis, mucosal morphometry, and mucin histochemistry and a functional study by analysis of transmucosal potential difference were performed in 27 patients with an ileoanal J-pouch after restorative proctocolectomy for ulcerative colitis. In 19 patients with a normal ileoanal pouch, two prospective follow-up analyses were performed after median functional pouch times of 14 and 39 months. We also evaluated eight patients with the diagnosis of pouchitis (median follow-up, 52.5 months). RESULTS: In the normal i…

AdultMalemedicine.medical_specialtyColonmedicine.medical_treatmentRectumGastroenterologyMembrane PotentialsAtrophyInternal medicinemedicineHumansProspective StudiesVillous atrophyIntestinal MucosaProspective cohort studyAgedInflammationProctocolectomybusiness.industryHistocytochemistryProctocolectomy RestorativeGastroenterologyMucinsGeneral MedicinePouchitisMiddle Agedmedicine.diseaseUlcerative colitismedicine.anatomical_structureColitis UlcerativeFemalePouchbusinessDiseases of the colon and rectum
researchProduct

Automatic Evaluation of Histological Prognostic Factors Using Two Consecutive Convolutional Neural Networks on Kidney Samples

2022

BACKGROUND AND OBJECTIVES: The prognosis of patients undergoing kidney tumor resection or kidney donation is linked to many histologic criteria. These criteria notably include glomerular density, glomerular volume, vascular luminal stenosis, and severity of interstitial fibrosis/tubular atrophy. Automated measurements through a deep-learning approach could save time and provide more precise data. This work aimed to develop a free tool to automatically obtain kidney histologic prognostic features. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In total, 241 samples of healthy kidney tissue were split into three independent cohorts. The “Training” cohort (n=65) was used to train two convoluti…

AdultMalemedicine.medical_specialtyEpidemiologyTubular atrophyUrologyKidneyCritical Care and Intensive Care MedicineConvolutional neural networkCortex (anatomy)medicineHumansAgedTransplantationKidneybusiness.industryDeep learningArea under the curveMiddle AgedPrognosismedicine.diseaseKidney NeoplasmsStenosismedicine.anatomical_structureNephrologyCohortOriginal ArticleFemaleNeural Networks ComputerArtificial intelligencebusinessClinical Journal of the American Society of Nephrology
researchProduct

Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy.

2014

Background and objective: Pepsinogen levels in plasma are increased by inflammation in the gastric mucosa, including inflammation resulting from Helicobacter pylori infection. A decrease in pepsinogen II level has been suggested as a reliable marker to confirm the successful eradication of infection. The aim of our study was to evaluate the potential role of pepsinogens I and II, gastrin-17 and H. pylori antibodies in confirming successful eradication. Material and methods: Altogether 42 patients (25 women, 17 men), mean age 45 years (range 23–74), were enrolled. Pepsinogens I and II, gastrin-17 and H. pylori IgG antibodies were measured in plasma samples using an ELISA test (Biohit, Oyj., …

AdultMalemedicine.medical_specialtyHelicobacter pylori infectionEfficacyGastrin-17macromolecular substancesPepsinogenGastroenterologydigestive systemHelicobacter InfectionsYoung AdultAtrophyPepsinInternal medicinePepsinogen AGastrinsmedicineGastric mucosaPepsinogen CHumansEradicationAgedMedicine(all)lcsh:R5-920biologyPlasma samplesHelicobacter pyloribusiness.industryHelicobacter pyloriMiddle Agedbiology.organism_classificationmedicine.diseaseAntibodies Bacterialdigestive system diseasesmedicine.anatomical_structureTreatment OutcomeGastric MucosaAutomotive Engineeringbiology.proteinPepsinogen IIPepsinogen; Gastrin-17; Eradication; <em>Helicobacter pylori</em>; EfficacyFemaleAntibodybusinesslcsh:Medicine (General)<em>Helicobacter pylori</em>BiomarkersMedicina (Kaunas, Lithuania)
researchProduct

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.

2014

Objective: The objective of this paper is to identify clinical or magnetic resonance imaging (MRI) predictors of long-term clinical progression in a large cohort of multiple sclerosis (MS) patients. Methods: A total of 241 relapsing–remitting (RR) MS patients were included in a nine-year follow-up (FU) study. The reference MRIs were acquired at baseline (BL) as part of a multicenter, cross-sectional, clinical-MRI study. Volumetric MRI metrics were measured by a fully automated, operator-independent, multi-parametric segmentation method. Clinical progression was evaluated as defined by: conversion from RR to secondary progressive (SP) disease course; progression of Expanded Disability Status…

AdultMalemedicine.medical_specialtyMagnetic resonance imaging follow-up multiple sclerosis clinical predictors gray matter atrophypredictormultiple sclerosisDisease courseDisability EvaluationMultiple Sclerosis Relapsing-RemittingInternal medicinefollow-upmedicineHumansSecondary progressiveExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosisDisease progressionFollow up studiesMagnetic resonance imagingclinical predictorsMiddle Agedmedicine.diseaseMagnetic Resonance Imaginggray matter atrophyCross-Sectional StudiesNeurologymultiple sclerosiDisease ProgressionSettore MED/26 - NeurologiaFemaleNeurology (clinical)businessNuclear medicineClinical progressionMRIFollow-Up StudiesMultiple sclerosis (Houndmills, Basingstoke, England)
researchProduct

Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability.

2007

Abstract Background Fatigue is a major problem in multiple sclerosis (MS), and its association with MRI features is debated. Objective To study the correlation between fatigue and lesion load, white matter (WM), and grey matter (GM), in MS patients independent of disability. Methods We studied 222 relapsing remitting MS patients with low disability (scores ≤ 2 at the Kurtzke Expanded Disability Status Scale). Lesion load, WM and GM were measured by fully automated, operator-independent, multi-parametric segmentation method. T1 and T2 lesion volume were also measured by a semi-automated method. Fatigue was assessed by the Fatigue Severity Scale (FSS), and patients divided in high-fatigue (FS…

AdultMalemedicine.medical_specialtyMultiple SclerosisStatistics as TopicGrey matterLesionWhite matterCentral nervous system diseaseDisability EvaluationAtrophyInternal medicinemedicineImage Processing Computer-AssistedHumansRisk factorFatigueAnalysis of VarianceBrain Mappingbusiness.industryMultiple sclerosisBrainmedicine.diseaseMagnetic Resonance ImagingSurgeryOxygenMultiple Sclerosis fatiguemedicine.anatomical_structureNeurologymultiple sclerosiFemaleNeurology (clinical)Analysis of variancemedicine.symptomAtrophybusinessbrain atrophyMRI
researchProduct

Phosphomannosyl receptors of lysosomal enzymes of skeletal muscle in neuromuscular diseases.

1988

The phosphomannosyl receptor system is responsible for both the receptor-mediated endocytosis and the intracellular transport of lysosomal enzymes. In the present study this receptor system was examined in affected muscles of patients with various neuromuscular diseases. The total activity of beta-N-acetyl-glucosaminidase, a marker enzyme of lysosomal hydrolases, was significantly elevated in the patients with myopathies (polymyositis and muscular dystrophies) but only slightly increased in those with neurogenic muscle atrophies (amyotrophic lateral sclerosis, polyneuropathy or other neurogenic muscle disease). The increase was most prominent in the group of polymyositis. The content of pho…

AdultMalemedicine.medical_specialtyNeuromuscular diseaseAdolescentReceptors Cytoplasmic and NuclearReceptors Cell SurfaceBiologyPolymyositisReceptor IGF Type 2Internal medicineLysosomemedicineHumansAmyotrophic lateral sclerosisMuscular dystrophyReceptorAgedMusclesSkeletal muscleGeneral MedicineNeuromuscular DiseasesMiddle Agedmedicine.diseaseMuscle atrophymedicine.anatomical_structureEndocrinologyNeurologyFemaleNeurology (clinical)medicine.symptomLysosomesActa neurologica Scandinavica
researchProduct

Treatment of masseteric hypertrophy with botulinum toxin: A report of two cases

2010

BAS, BURCU/0000-0003-0593-3400; Kutuk, Nukhet/0000-0001-6563-1899 WOS: 000279667400021 PubMed: 20173718 Masseter muscle hypertrophy is a rare condition of unknown cause which is important in the differential diagnosis of head and neck masses, located in the cheek. Several treatment options reported for masseter hypertrophy, which range from simple pharmacotherapy to more invasive surgical reduction. Botulinum toxin type A is a powerful neurotoxin which is produced by the anaerobic organism Clostridium botulinum and when injected into a muscle causes interference with the neurotransmitter mechanism producing selective paralysis and subsequent atrophy of the muscle. Injection of botulinum tox…

AdultMalemedicine.medical_specialtyNeurotoxinsmedicine.disease_causeMuscle hypertrophyMasseter muscleAtrophyParalysismedicineNeurotoxinHumansBotulinum Toxins Type AGeneral Dentistrybusiness.industryMasseter MuscleHypertrophyCheekmedicine.disease:CIENCIAS MÉDICAS [UNESCO]SurgeryMasseter musclebotulinum toxin type Amedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASClostridium botulinumSurgeryFemalemedicine.symptomDifferential diagnosisbusinesshypertrophy
researchProduct

Meibomian glands structure in daily disposable soft contact lens wearers: a one‐year follow‐up study

2020

Purpose To assess the impact of daily disposable soft contact lenses on meibomian gland morphology over a period of 12 months. Methods Forty-one subjects (33 experienced and 8 neophytes) were fitted with either silicone-hydrogel or hydrogel daily contact lenses. The study protocol included four visits: baseline, day-2 for contact lens fit and follow-up measurements, as well as after 6 and 12 months of lens wear. Non-contact infrared meibography images were acquired with Keratograph 5M topographer (www.oculus.de) and analysed with an automated method, which objectively estimates the area of gland atrophy, gland length and width, number of glands and gland irregularity. Protocol at follow-up …

AdultMalemedicine.medical_specialtyOne year follow upMeibomian glandlaw.inventionYoung Adult03 medical and health sciences0302 clinical medicineAtrophylawOphthalmologyHumansMedicineOcular Surface Disease IndexProspective StudiesVision Ocularbusiness.industryOsmolar ConcentrationMeibomian GlandsContact Lenses Hydrophilicmedicine.diseaseeye diseasesSensory SystemsLens (optics)Contact lensOphthalmologymedicine.anatomical_structurePatient SatisfactionTears030221 ophthalmology & optometryFemaleDaily disposablesense organsbusinessEarly phase030217 neurology & neurosurgeryFollow-Up StudiesOptometryOphthalmic and Physiological Optics
researchProduct